GlaxoSmithKline will begin trials of its arthritis drug in COVID-19 patients at the end of the month. The drug, otilimab, will be tested on patients suffering from pneumonia related to coronavirus. About 800 patients will be enrolled and results are expected at the end of 2020. (Reuters)
Moderna expects to begin mid-stage coronavirus vaccine trials in mid-May. Late-stage studies are expected to begin in the summer. Moderna is currently testing its experimental vaccine in an early trial. (Reuters)
Amazon has invested in a wide range of coronavirus efforts. The company is funding clinical trials, delivering tests to healthcare workers and offering its employees’ expertise to building coronavirus information websites and speaking at events. (STAT)
UnitedHealth will offer its members credit toward their premiums and bills. The company is one of few not struggling due to the pandemic. It is making $1.5 billion available to people enrolled in its plans through credits. (The New York Times)
Medtech company Becton Dickinson planned to ramp up manufacturing to prepare for a second wave of COVID-19. The company manufactures several tests, including a diagnostic kit that has results in two to three hours and an antibody test that can confirm current or past exposure to COVID-19 in as little as 15 minutes. (Reuters)
The post Five things for pharma marketers to know: Friday, May 8, 2020 appeared first on MM&M – Medical Marketing and Media.
